Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Data sources
SEC Form 4
43m ago
House PTR
42m ago
SEC 13F
42m ago
Robinhood Chain
42m ago
Adagene Inc. (ADAG) · INSIDER
Public company
Adagene Inc.
ADAG
CIK 0001818838
EDGAR filings
Open in network
○
Watch ADAG
Price
$2.00
1 year
+17.6%
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
7
Connections with evidence
2
Customize layout
ADAG · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
7
GU
Grawunder Ulf
Director
ADAG
Adagene Inc.
Grant or award · 10b5-1 plan
A
—
20.0K sh
Aug 13, 2026
Aug 14, 2026
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Insider of
evidence
Grawunder Ulf
Director · Aug 14, 2026
traded Aug 13, 2026
+1d
SEC Form 4
Evidence
Evidence
Close
Disclosed trades
TradingView